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ABSTRACT 
tRNAs are small RNA molecules that function by delivering amino acids to the ribosome 
during translation. The focus of this work is to understand how tRNA moves from its site of 
synthesis in the nucleus to its site of function in the cytoplasm in yeast. The -importin protein 
family member, Los1, binds to end-processed tRNAs in the nucleus and exports them to the 
cytoplasm. However, since Los1 is unessential, additional nuclear export tRNA pathways must 
exist. Our lab has identified two additional -importins, Msn5 and Crm1, which cause tRNA 
nuclear accumulation when mutated. 
This study seeks to determine if Los1, Msn5, and Crm1 are the only proteins involved in 
tRNA nuclear export? Towards this goal, I have constructed yeast strains bearing multiple 
mutations of the known genes. Should the crm1-1 msn5 los1 triple mutant be viable, it will 
suggest there are other unidentified tRNA nuclear pathways. However, if the triple mutant is not 
viable, then possibly Los1, Msn5, and Crm1 are the only tRNA export pathways. Previously, the 
los1 msn5 double deletion was determined to be viable. The crm1-1 msn5 and crm1-1 
los1Δ double mutant are viable and, interestingly, they both display increased temperature 
sensitivity when compared with either single mutant or the los1Δ msn5Δ double mutant. 
Therefore, the crm1-1 mutation coupled with the deletion of los1 or msn5 likely further impairs 
the export of tRNA from the nucleus.  Because the double mutants are viable, I am constructing 
the triple crm1-1 msn5Δ los1Δ mutant. 
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CHAPTER 1: INTRODUCTION 
tRNAs are small RNA molecules that are responsible for delivering amino acids to the 
ribosome for polymerization into a polypeptide during translation. They are synthesized in the 
nucleus as a primary transcript containing extra sequences on the 3’ and 5’ ends.  Approximately 
25% of yeast tRNAs also contain introns located one nuceleotide 3’ to  the anti-codon.  
Maturation of tRNA involves nuclear removal of the 3’ and 5’ ends, removal of introns by the 
splicing endonuclease, and various other nucleotide modifications occurring in the nucleus and 
cytosol.  In yeast, unlike mammalian cells, the splicing endonuclease is located on the surface of 
the mitochondria [31,32].  Functioning as an adaptor molecule, tRNA facilitate the translation of 
an mRNA transcript into proteins.  These molecules are necessary for proteins synthesis, which 
occurs in the cytoplasm at the ribosomes, and therefore tRNA export from their nuclear site of 
synthesis to the cytoplasm is essential. 
tRNA transport is a dynamic, regulated, multidirectional process that determines the 
nuclear-cytosolic distribution of tRNA within the cell.  The identification of mutations and 
stressors that alter the nuclear-cytosolic distribution of tRNA have aided our understanding of 
tRNA nuclear export.  A wild-type cell grown in rich media has an even distribution of tRNA 
throughout the cell.  However, blocked tRNA export, defective tRNA 3’ end formation, 
inhibition of aminoacylation, and nutrient deprivation will cause tRNA nuclear accumulation 
[29,23,24].  The current model of tRNA transport (Figure 1.1) has three distinctive steps: 
primary tRNA nuclear export, retrograde tRNA transport (import), and re-export.  Due to the 
mitochondrial location of the splicing endonuclease [31,32], primary tRNA nuclear export is 
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distinguishable from  re-export in yeast, as primary export defects cause accumulation of intron-
containing pre-tRNA. 
Los1, a β-importin protein family member, binds to end-processed tRNAs in the nucleus 
and exports them to the cytoplasm [1,6,12,15,17,21].  Deletion of LOS1 causes accumulation of 
intron-containing tRNA indicating that Los1 has a role in the primary tRNA export pathway.  As 
los1 cells accumulate every family of tRNA within the nuclei and Los1 binds mature tRNA, it is 
also likely to function in re-export.  Despite the importance of tRNA nuclear export, LOS1 is 
surprisingly unessential [13].   The unessential nature of LOS1 has been demonstrated in other 
organisms containing LOS1 homologues such as S. pombe and Arabidopsis [20].   The 
nonessential character of LOS1 indicates that loss of the gene is likely compensated for by other 
genes that function in a similar fashion.  Moreover, there is evidence that certain arthropods have 
no endogenous LOS1 homologue [25].  These data indicate that there is another protein or 
proteins involved in the nuclear export of tRNA. 
Msn5 is another protein that may play a role in the export of nuclear tRNAs.  Msn5 is a 
-importin that functions in pre-microRNA and tRNA export in Drosophila [11,25].  In yeast, 
Msn5 has been indicated in exporting transcription factors to the cytoplasm in response to 
nutrient availability [4,8].  The likelihood of Msn5 affecting nuclear export is evidenced by 
MSN5 deletions resulting in tRNA nuclear accumulation when coupled with LOS1 deletions 
[28]. Furthermore, Msn5 has been demonstrated to co-purify with other proteins shown to play a 
role in tRNA nuclear-cytoplasmic dynamics, namely Cex1 and Utp8 proteins [19,27].  Despite 
the implication of Msn5 being involved in tRNA nuclear export, it is unlikely this is the only 
other protein involved, as los1Δ msn5Δ double mutants do not display increased growth defects.  
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Synthetic lethality, or at least synthetic growth defects, would be expected if Los1 and Msn5 
were the only proteins involved in tRNA nuclear export. 
It has been shown that under several circumstances, namely defects in tRNA 3’-end 
formation and aminoacylation and during amino acid starvation tRNA accumulates in the 
nucleus.  Interestingly, these tRNAs that accumulate do not contain introns [2,5].  Because these 
spliced tRNAs accumulate in the nucleus and the tRNA splicing machinery is located on the 
surface of the mitochondria [31,32], it reasons that tRNA is capable of being exported from the 
nucleus to its site of function in the cytoplasm and is then able to be imported in a retrograde 
manner back into the nucleus.  This hypothesis was tested and supported by data showing the 
mitochondrial tRNA splicing machinery does not relocate to the nucleus under the same 
conditions [23].  Utilizing heterokaryon assays, yeast cells modified to produce tRNA from 
another organism were mated with yeast cells that were incapable of nuclear fusion and capable 
only of endogenous tRNA production.  The result was that both nuclei were able to accumulate 
tagged tRNA despite only one nuclei producing it.  This is strong evidence for the retrograde 
pathway of tRNA transport [23,28].  Additionally, the accumulation observed was determined 
not to be due to new transcription via the use of a tRNA transcription inhibitor [29].  As a result, 
retrograde movement was demonstrated for multiple independent families of tRNAs [28].   
The role of nutrient availability and tRNA accumulation was broadened by other studies 
demonstrating that yeast cells deprived of amino acid [23], glucose [29], and phosphate [14] all 
led to nuclear accumulation of cytoplasmic tRNA, and that these nuclear tRNAs are re-exported 
upon resupplying the cells with the deprived nutrient [14,23,29]. 
Concordantly, it has been found that tRNA nuclear accumulation does not occur in 
mutants lacking another β-importin family, Mtr10.  In mtr10Δ cells deprived of amino acids, 
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phosphate, or glucose did not result in the nuclear accumulation of tRNA [14,23,29].  Mtr10 is 
responsible for shuttling tRNAs from the cytoplasm back into the nucleus in a retrograde 
fashion.  The biological function of shuttling tRNAs back into the nucleus is still unknown, but 
possible hypotheses include sequestration for proofreading allowing the cell the opportunity to 
check for proper tRNA aminocylation.  An alternative hypothesis is that the retrograde pathway 
functions as a mechanism to downregulate overall protein synthesis during stress conditions.  
Once these previously cytoplasmic tRNAs have been shuttled back to the nucleus they are able 
to be re-exported again by the same Los1, Msn5 and other unknown proteins. 
The retrograde pathway is conserved in vertebrate cells. Employing rat hepatoma H4IIE, 
Shaheen et al (2007) showed that amino acid deprivation caused nuclear accumulation of tRNA 
(even with tRNA transcription inhibitors). The study showed that the nuclear accumulated 
tRNAs are re-exported once amino acids are supplied to the cells [24].  The data indicate the 
process in vertebrate functions in a similar manner to the studies involving S. cerivisiae. 
Previously, our lab identified an essential gene, CRM1, which may play a role in the 
export of tRNAs from the nucleus.  Crm1 is a β-importin known to play a major role in protein 
and RNA export from the nucleus [15]. During a screen of yeast with mutations in genes 
encoding all known exportins and importins implicated in RNA metabolism it was identified that 
a temperature sensitive crm1-1 allele accumulated tRNA in the nucleus [2].  Since the crm1-1 
mutant displays tRNA nuclear accumulation at non-permissive temperature, it is a possible 
candidate for involvement in the export pathway. 
The question we proposed is: Are Crm1, Los1 and Msn5 the only proteins involved in the 
process of tRNA nuclear export?  As CRM1 is an essential gene it cannot be deleted, so to 
answer the question a temperature sensitive mutant allele of CRM1 was utilized, crm1-1.  This 
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temperature sensitive (ts) mutation allows for a way to bypass the essential nature of the gene by 
temperature inactivation.  At the non-permissive temperature, such a ts mutant acts as though the 
gene were deleted.  Starting with a crm1-1 strain, two different double mutants were created 
utilizing the genes known to be involved in the pathway.   
The double mutants of crm1-1 msn5Δ and crm1-1 los1Δ displayed increased temperature 
sensitivity when compared to the wild type, crm1-1, msn5Δ, los1Δ single mutants, and the los1Δ 
msn5Δ double mutant (Figure 3.2).  As the crm1-1 msn5Δ and crm1-1 los1Δ double mutants 
have been found to be viable I am creating the triple mutant crm1-1 los1Δ msn5Δ.  Should the 
triple mutant be viable, it will indicate there are likely other unknown proteins involved the 
pathway.  Conversely, should the triple mutant be lethal it is a strong indication that Crm1, 
Msn5, and Los1 are the major players in the pathway. 
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FIGURE 1.1 
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CHAPTER 2: MATERIAL AND METHODS 
Strains and Media 
Strains used in this study are listed in Table 2.1.  Strains were initially grown in yeast 
extract peptone dextrose media (YEPD).  Transformants were selected by growing strains on 
YEPD+ cloNat (100 mg/L; Werner BioReagents), YEPD+ Hygromycin (6 mL/L; Cal Biochem), 
or -URA media (synthetic defined media lacking uracil). 
 
Strain Construction 
The deletions were achieved by lithium acetate transformation [28].  Using 1.5 mL of 
culture, cells were grown overnight, pelleted and resuspended in 100µL OSB buffer (0.1M 
lithium acetate, 0.05 M DTT, 40% polyethelene glycol, 0.5 mg/mL single-stranded salmon 
sperm DNA).  Then 10 µL of plasmid DNA or PCR product was added to each reaction.  The 
reaction mixes were incubated for 20 min at 45°C.  For nutritional markers the reaction mixture 
was plated following incubation directly onto -URA media.  For drug selection markers the 
reaction mixture was allowed to grow non-selectively in 2mL YEPD media for 3-6 hours.  The 
cultures were then pelleted in 1.5 mL eppendorf tubes and plated on drug selective media. 
All oligonucleotides used in this study are listed in Table 2.2. To create the PCR product 
for replacing the endogenous MSN5, primers WHIT59 and WHIT60 were used to amplify the 
natMX4 template by employing PCR [29].  Essentially, this utilizes the sequence homology of 
MSN5 shared with the WHIT59 and WHIT60 primers to target the NAT
R
 gene to replace the 
endogenous MSN5 gene (Figure 1.2).  The 3’ ends of WHIT59 and WHIT60 share sequence 
homology with the template allowing for PCR amplification.  The creation of the PCR product to 
replace the endogenous LOS1 with HPH
R
 was done in a similar fashion (Figure 1.3).  The same 
10 
 
strategy of homology was utilized, however primers RLH007A and RLH007B shared sequence 
homology with the hphMX4 and the 3’ ends shared homology with the template allowing for 
PCR amplification. 
Subsequently, in order to create the crm1-1 los1Δ msn5Δ triple mutant the crm1-1 los1Δ 
and crm1-1 msn5Δ double mutants are both utilized in a two angled approach (Figure 3.4).  Each 
double mutant was transformed with a covering plasmid to complement for the loss of the 
deleted gene.  If Crm1, Los1, and Msn5 are the major proteins involved in the pathway, it is 
likely that the cells will not be viable.  Complementation allows for a way to bypass the potential 
lethality of the triple mutant by supplying a functional copy of one of the deleted genes.  Once 
the triple mutant is transformed and confirmed, selection for the loss of the covering plasmid is 
necessary to assay the cells viability.  If the triple mutant is viable, it indicates that there are other 
proteins involved in the pathway. 
 
Preparation of Genomic DNA 
 Single colonies were selected from streaks of transformation candidates and grown to 
saturation in 2 mL of YEPD.  Cells were pelleted and cell walls were digested by resuspension in 
200 µL of zymolyase solution.  DNA was purified by phenol/chloroform extraction and 
precipitated by ethanol treatment.  The DNA was then dissolved in sterile water for use as a 
template during PCR.   
 
Confirmation of Genomic DNA 
To confirm the knockout of MSN5 in the crm1-1 msn5Δ double mutant primers were 
selected and the genomic DNA was PCR amplified utilizing JJH001 and JJH002 or JJH003 and 
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JJH004 to confirm the deletion of MSN5.  The method utilized one primer designed to hybridize 
within the gene and another to hybridize outside of the integration area.  Agarose gel 
electrophoresis was used to analyze the PCR products (Figure 3.1).   Candidates that have had 
their endogenous MSN5 replaced will lack the band corresponding to these primers. JJH001 and 
RLH025C or JJH004 and RLH025A were used to confirm the proper integration of natMX4.  
Again, the strategy was to hybridize to a region inside the inserted gene and another region 
outside the recombination area. Candidates that have had a successful integration of natMX4 will 
display a band corresponding to these primers.  By utilizing both natMX4 and MSN5 primers it 
allows for both confirming the presence of natMX4 and the confirming absence of MSN5.  If 
both are successful it indicates proper integration.   
Confirming the replacement of LOS1 with hphMX4 is achieved in the same manner 
(Figure 3.1).  The difference being that primers 7 and 12 or RLH010A and RLH010B are used 
for detecting the presence of LOS1 and RLH025B and RLH010B are used for confirming the 
integration of hphMX4.  Again, candidates that both lack the band corresponding to LOS1 and 
possess the band corresponding to hphMX4 are successful candidates. 
 
Plasmids 
Plasmids used in this study are listed in Table 2.3.  The YCp MSN5 plasmid was 
constructed by digesting MSN5 with restriction enzymes XhoI and NheI and the resulting 
fragment was purified.  pRS416 was digested at the multiple cloning site with XhoI and SpeI.  
The fragments were purified and ligated together using T4 DNA ligase (New England BioLabs) 
and the ligation product was transformed in chemical competent E. coli; colonies that displayed 
ampicillin resistance were analyzed further. 
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Yeast Growth Assay 
 Spot assays were performed by growing cultures in YEPD media to saturation.  The 
optical density (A600) of the cultures was obtained by spectrophotometry, and the density was 
equalized to the lowest optical density culture.  A series of four serial dilutions of each culture 
were created with each diluted by ten fold.  Five µL of each dilution was plated on five YEPD 
plates and incubated at 23°C, 30°C, 34°C, 37° or 39°C.  Pictures were taken between 24-48 h 
after spotting.  Photoshop CS3 (Adobe) was used for assembling the images. 
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CHAPTER 3: RESULTS 
Phenotype of Double Mutants 
 The MSN5 and LOS1 genes are known to function in the export of nuclear tRNA to the 
cytoplasm.  CRM1 is an essential gene that may also be involved in the same pathway.  
However, since CRM1 is an essential gene, a temperature sensitive (ts) strain, crm1-1, was 
utilized.  Starting with the crm1-1 strain, MSN5 was knocked out by replacing the endogenous 
gene with a NAT
R
 drug resitance marker (Figure 3.4).  This was accomplished by creating PCR 
products with sequence homology to the MSN5 gene directly upstream and downstream of the 
NAT
R
 marker and using homologous recombination (Figure 1.2).  Genomic DNA of the crm1-1 
msn5Δ double mutant was prepared.  Primers were used to amplify the genomic DNA by PCR.  
The PCR product was analyzed and the crm1-1 msn5Δ double mutant was confirmed by agarose 
gel electrophoresis (Figure 3.1).  The absence of an expected 715 bp band indicates MSN5 is not 
present, and the presence of a 507 bp band indicates the integration of natMX4.  Therefore, lanes 
3 and 4 correspond to successful transformants. 
The phenotype of the crm1-1 msn5Δ double mutant was assessed by spot assay to 
evaluate the growth of the double mutant.  At 30°C, crm1-1 msn5Δ shows a reduced growth rate 
compared to the wild type, losΔ, msn5Δ, or the los1Δ msn5Δ double mutant.  At 34°C, the crm1-
1 msn5Δ double mutant also shows increased temperature sensitivity compared to those at 30°C, 
but the interesting difference at 34°C is that the crm1-1 msn5Δ mutant displays greater 
temperature sensitivity than the crm1-1 strain. 
The crm1-1 msn5Δ double mutant was transformed with a covering plasmid, to allow for 
complementation of the deleted gene.  The initial plasmid, MSN5 MORF [3], was a high copy 
plasmid and was under a GAL inducible promoter.  In the past, members of our lab have 
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experienced synthetic growth defects as a result of high copies of MSN5.  When the double 
mutant was transformed with the MSN5 MORF plasmid the cells displayed a phenotype of 
reduced growth (data not shown).   It is likely that the overproduction of Msn5 as a result of 
GAL induction resulted in cellular toxicity.  Utilizing a low copy plasmid with MSN5 under the 
endogenous promoter may rescue the growth defect. 
Therefore, a centromeric plasmid, YCpMSN5, was constructed by digesting the pRS416 
plasmid [26] (a centromeric plasmid) and MSN5 with the endogenous promoter from the 
YEpMSN5 (Open Biosystems).  MSN5, with the endogenous promoter, was ligated into the 
pRS416 multiple cloning site.  The plasmid construct was transformed into chemical competent 
E. coli cells and colonies displaying ampicillin resistance were isolated.   The plasmid was 
transformed into the crm1-1 msn5Δ double mutant.  YCpMSN5 did not result in the reduced 
growth displayed by the previous plasmid (data not shown), thereby improving the cells viability 
and transformation efficiency. 
The crm1-1 msn5Δ double mutant harboring YCpMSN5 was then used to attempt creation 
of the crm1-1 msn5Δ los1Δ triple mutant.  This transformation was performed multiple times and 
resulted in either no candidates or false positive transformants.  However, during the 
transformations to delete LOS1 in the crm1-1 msn5Δ double mutant, the crm1-1 single mutant 
was used as a control, and from the crm1-1 control, candidates of crm1-1 los1Δ were confirmed 
as successful transformants.  Genomic DNA of the crm1-1 los1Δ double mutant was prepared 
and primers were used to amplify the DNA by use of PCR.  The PCR product was analyzed by 
agarose gel electrophoresis and the crm1-1 los1Δ double mutant was confirmed (Figure 3.1). The 
absence of the expected 674 bp band indicates LOS1 is not present, and the presence of a 973 bp 
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band indicates the integration of hphMX4 gene. Therefore, lane 2 indicates a successful 
transformant. 
The phenotype of the crm1-1 los1Δ double mutant was ascertained by spot assay (Figure 
3.2).  The temperature sensitivity of crm1-1 los1Δ at 30°C is drastically increased compared to 
the wild type, los1Δ, msn5Δ, crm1-1, and los1Δmsn5Δ.  Moreover, crm1-1 los1Δ also displays a 
reduced growth rate compared to crm1-1 msn5Δ at 30°C. 
With the addition of crm1-1 los1Δ the two angled approach of transforming both double 
mutants is being used to expedite the process of creating the triple mutant.  The crm1-1 los1Δ 
double mutant was transformed with a covering plasmid YCpLOS1, supplying the cell with a 
functional copy of LOS1 under the endogenous promoter.  If Crm1, Los1, and Msn5 are the only 
proteins involved in the pathway, a triple mutant would likely not be viable.  YCpLOS1 allows 
for complementation to prevent this possible lethality.  The triple mutant crm1-1 los1Δ msn5Δ 
has yet to be attained. 
 When the triple mutant is confirmed, the next step is to select for the loss of the covering 
plasmid.  Both of the covering plasmids used contain a URA3 marker, which will cause cells 
grown on 5FOA media to produce a toxic compound.  This will select for the loss of the plasmid.   
This raises the possibility that if Crm1, Los1 and Msn5 are the only genes involved in this 
critical pathway, then a triple mutant may not be viable without a covering plasmid.  
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B 
Figure 3.1: PCR Confirmation of crm1-1 msn5Δ and crm1-1 los1Δ 
candidates.  (A) Absence of expected 715 bp band in lanes 3 and 4 
indicate MSN5 is not present.  (B) Presence of expected 507 bp band in 
lanes 3 and 4 indicate integration of natMX4. Multiple bands present in 
WT and crm1-1 are consistent with known nonspecific bands.  (C) 
Absence of expected 674 bp band in lane 2 indicates LOS1 is not 
present.  (D) Presence of expected 973 bp band in lane 2 indicates 
integration of hphMX4. 
C 
D 
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Figure 3.4 
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CHAPTER 4: DISCUSSION 
 Individually, the deletion of MSN5 or LOS1 results in no noticeable phenotype.  
These genes are unessential and furthermore the double deletion of los1Δ msn5Δ also has no 
significant phenotype.  However, when MSN5 or LOS1 is deleted from the crm1-1 mutant strain 
there is a substantial phenotype of temperature sensitivity.  The spot assays conducted showed 
that the crm1-1 msn5Δ and crm1-1 los1Δ double mutants were more sensitive to temperature 
than crm1-1 at 34°C.  Interestingly, the crm1-1 los1Δ double mutant does not grow at 30°C, a 
substantial shift from both crm1-1 and crm1-1 msn5Δ (Figure 3.2).  The reduced growth rate of 
crm1-1 los1Δ at 30°C when compared to the crm1-1 msn5Δ double mutant is of significance. 
Los1 has been shown to be involved in both the export of newly synthesized tRNA and the re-
export of tRNA that has been shuttled back to the nucleus.  Msn5 has been shown to function in 
the re-export of tRNA; however, export of newly synthesized tRNA has not been demonstrated.  
If the main role of Msn5 is involved with only the re-export of tRNA, then deleting LOS1 would 
should a more significant impact on nuclear-cytoplasmic dynamics than MSN5.  The data 
produced in this study support the hypothesis that the main role of Msn5 is involved in the re-
export of tRNA rather than the export of newly synthesized tRNA, based on the relative 
temperature sensitivity. 
The function of Crm1 on nuclear-cytoplasmic dynamics is still unknown. Nonetheless, 
the data in this study would point towards Crm1 having a major role in the pathway.  Previous 
data [2] have shown that the crm1-1 single accumulates tRNA lacking introns.  However, there 
was also a small amount of tRNA containing introns observed.  Due to the previous data, as well 
as the double mutant phenotypes observed in this study, it suggests that Crm1 is involved in both 
export of newly synthesized tRNA and re-export of tRNA shuttled back into the nucleus. 
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It cannot be ruled out that stacking most any unessential deletion in one strain would 
result in synthetic growth defects.  While that is possible, it would be likely that in this case the 
double mutant los1Δ msn5Δ would display increased temperature sensitivity in a similar fashion 
to crm1-1 msn5Δ and crm1-1 los1Δ.  Since this is not the case, I argue that it is unlikely that the 
phenotype of increased temperature sensitivity in the crm1-1 msn5Δ and crm1-1 los1Δ double 
mutants are a result of multiple unrelated mutations.  Rather, it is likely due to the genes in 
question having a role in the same pathway.  Therefore, while not conclusive, it is reasonable to 
suggest that Crm1, Msn5 and Los1 have similar functions and the presence of one is at least 
partially able to compensate for mutations in another. 
Unfortunately, due to time constraints the crm1-1 los1Δ msn5Δ triple mutant has yet to be 
created.  The most important future goal of this research is to confirm a crm1-1 los1Δ msn5Δ 
triple mutant.  From there, the next step would be to select for the loss of the covering plasmid.  
Since the covering plasmids used have a URA3 marker, plating the triple mutant on 5FOA media 
results in a toxic intermediate and will select for cells that have lost the plasmid.   
If loss of the plasmid results in viable cells it is likely there are other proteins involved in 
this pathway.  Identifying further suspect genes could be performed by genome wide screens 
looking for nuclear accumulation of tRNA or by comparison of known genes and proteins to 
those in the Saccharomyces Genome Database. If candidates are unable to be obtained on 5FOA 
media it indicates that without a covering plasmid the cells are not viable.  That conclusion 
would suggest that Crm1, Los1 and Msn5 are the major proteins functioning in this pathway. 
However if candidates can be obtained on 5FOA media it suggests that there are other 
proteins involved in the export of nuclear tRNAs.  It would not be unreasonable to suggest cells 
would have redundancy or similar functioning proteins for maintaining a vital function.  tRNA 
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plays an essential role in cell biology due to the role in protein synthesis.  It would seem to be 
advantageous for a cell to have redundancy in this pathway to allow for complex regulation of 
tRNA nuclear export pathways. 
 
Possible Future Experiment 
 Should the triple mutant prove to be lethal without a covering plasmid there are options 
that may allow for further study of the mutant. One option would be to select for suppressors that 
would rescue viability by returning partial function of the pathway.  Another option would be by 
deleting MTR10 (Fig. 1.1), that functions in the import of once cytoplasmic tRNAs, it may be 
possible to circumvent the lethality of the triple mutant.  The idea is thatiIf cytoplasmic tRNAs 
are required for viability, knocking out the re-import mechanism (MTR10) may allow enough 
tRNA to be retained in the cytoplasm for viability to be maintained.  If this crm1-1 los1Δ msn5Δ 
mtr10Δ quadruple mutant is viable it will allow for further study of the pathway and deeper 
elucidation of tRNA nuclear and cytoplasm dynamics. 
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